Quest Diagnostics Reports First Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Quest Diagnostics (DGX) PT Raised to $102 at SunTrust
April 23, 2019 3:50 PM EDTSunTrust analyst David MacDonald raised the price target on Quest Diagnostics (NYSE: DGX) to $102.00 (from $96.00) while maintaining a Hold rating.
solid execution in a tough environmentlong-term the big guys win... MoreQuest Diagnostics (DGX) Tops Q1 EPS by 4c
April 23, 2019 6:46 AM EDTQuest Diagnostics (NYSE: DGX) reported Q1 EPS of $1.40, $0.04 better than the analyst estimate of $1.36. Revenue for the quarter came in at $1.89 billion versus the consensus estimate of $1.87 billion.
Outlook for full-year 2019 remains unchangedFor earnings history and earnings-related data on Quest Diagnostics (DGX) click here.
... More